Toyama Prefecture, Toyama Medical's global headquarters.
The Research and Development Department's conference room.
The long white table and bright white walls made the entire conference room spotless.
The employees in white uniforms sat around the conference table, respectfully looking toward the head of the table.
Chief Araki Koichi of the Research and Development Department was a short, stout old man wearing thin-rimmed glasses. Holding a manuscript, he read with a faint smile:
"This week, the Baltic States approved the sale of our new brain cancer drug. Several local medical companies have already expressed interest in placing orders, and we expect to receive orders for thirty thousand doses!"
"The FDA is about to approve the brain cancer drug, and the first batch of orders will exceed one hundred thousand doses! Approval on the mainland is also progressing smoothly. According to our information, five of the six review teams have passed us, and the last team should approve us quickly as well!"
"The company's performance has grown dramatically, and the Board of Directors has approved a collective salary increase for everyone in our Research and Development Department. In particular, all personnel involved in developing the brain cancer drug will be promoted by one grade. The only exception is Hatayama Ryunosuke, who interfered with the research and development and has been demoted from Grade A to Grade B!"
Araki raised his head, and everyone present happily burst into applause.
Bang! The conference room door was suddenly shoved open.
The applause stopped abruptly. Everyone turned to look, frowning deeply.
A bespectacled man stood at the door, panting heavily. He swept his gaze across the room, bowed, and stammered, "Everyone! Please... please consider recalling the brain cancer drug that's already been sold! I insist... the brain cancer drug has major safety risks!"
After speaking, the